Twist Bioscience to Provide Target Enrichment Products for MGI in Europe and Asia Pacific

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MGI International Sales Co., Limited (MGI), a subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement for Twist Bioscience’s target enrichment product line in Europe and Asia Pacific. Under the terms of the non-exclusive agreement, the two companies ar

Click to view original post